A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy

Journal of Diabetes and its Complications

Volumn 31, Issue 8, 2017, Pages 1348-1353

  Vujosevic, Stela ^a   Pucci, Porzia ^a   Casciano, Margherita ^a   Daniele, AnnaRita ^a   Bini, Silvia ^a   Berton, Marianna ^a   Cavarzeran, Fabiano ^a   Avogaro, Angelo ^a   Lapolla, Annunziata ^b   Midena, Edoardo ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b ULSS 16   (Italy)

^c IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Diabetic maculopathy; Diabetic retinopathy screening; Epidemiology; Sight threatening diabetic retinopathy; Telemedicine

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC MACULOPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; DISEASE SEVERITY; EYE COLOR; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; KAPLAN MEIER METHOD; LOG RANK TEST; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPROLIFERATIVE DIABETIC RETINOPATHY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROLIFERATIVE RETINOPATHY; RECEIVER OPERATING CHARACTERISTIC; RETINA MACULOPATHY; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TELEMEDICINE; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DISEASE EXACERBATION; MASS SCREENING; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TELEMEDICINE; YOUNG ADULT;

EID: 85019645793     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2017.04.010     Document Type: Article

References (32)

1. 1. Quartilho, A., Simkiss, P., Zekite, A., Xing, W., Wormald, R., Bunce, C., Leading causes of certifiable visual loss in England and Wales during the year ending 31 march 2013. Eye (Lond) 30 (2016), 602–607.
2. 2. King, H., Aubert, R.E., Herman, W.H., Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 21 (1998), 1414–1431.
3. 3. Klein, R., Klein, B.E., Moss, S.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984), 527–532.
4. 4. Klein, R., Klein, B.E., Moss, S.E., et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984), 520–526.
5. 5. Broe, R., Rasmussen, M.L., Frydkjaer-Olsen, U., et al. The 16-year incidence, progression and regression of diabetic retinopathy in a young population-based Danish cohort with type 1 diabetes mellitus: The Danish cohort of pediatric diabetes 1987 (DCPD1987). Acta Diabetol 51 (2014), 413–420.
6. 6. Yau, J.W.Y., Rogers, S.L., Kawasaki, R., et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35 (2012), 556–564.
7. 7. Garvican, L., Clowes, J., Gillow, T., Preservation of sight in diabetes: Developing a national risk reduction programme. Diabet Med 17 (2000), 627–634.
8. 8. American Diabetes Association, Diabetic retinopathy. Diabetes Care 21 (1998), 157–159.
9. 9. Royal College of Ophthalmologists, Guidelines for diabetic retinopathy. 1997, 1–104 [London].
10. 10. Bachmann, M.O., Nelson, S.J., Impact of diabetic retinopathy screening on a British district population: Case detection and blindness prevention in a evidence based model. J Epidemiol Community Health 52 (1998), 45–52.
11. 11. Jones, C.D., Greenwood, R.H., Misra, A., Bachmann, M.O., Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 35 (2012), 592–596.
12. 12. Agardh, E., Tababat-Khani, P., Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy. Diabetes Care 34 (2011), 1318–1319.
13. 13. Looker, H.C., Nyangoma, S.O., et al., Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative. Predicted impact of extending the screening interval for diabetic retinopathy: The Scottish diabetic retinopathy screening programme. Diabetologia 56 (2013), 1716–1725.
14. 14. Porta, M., Maurino, M., Severini, S., et al. Clinical characteristics influence screening intervals for diabetic retinopathy. Diabetologia 56 (2013), 2147–2152.
15. 15. Olafsdóttir, E., Stefánsson, E., Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol 91 (2007), 1599–1601.
16. 16. Stratton, I.M., Aldington, S.J., Taylor, D.J., Adler, A.I., Scanlon, P.H., A simple risk stratification for time to development of sight-threatening diabetic retinopathy. Diabetes Care 36 (2013), 580–585.
17. 17. Vujosevic, S., Benetti, E., Massignan, F., et al. Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7standard early treatment diabetic retinopathy study fields. Am J Ophthalmol 148 (2009), 111–118.
18. 18. Bursell, S.E., Cavallaro, J.D., Cavallaro, A.A., et al. Stereo nonmydriatic digital-video color retinal imaging compared with EarlyTreatment diabetic retinopathy study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 108 (2001), 572–585.
19. 19. Global Diabetic Retinopathy Project Group, Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scale. Ophthalmology 110 (2003), 1677–1682.
20. 20. Segato, T., Midena, E., Grigoletto, F., et al. The epidemiology and prevalence of diabetic retinopathy in the Veneto region of north east Italy. Veneto Group for Diabetic Retinopathy. Diabet Med 8 (1991), S11–S16.
21. 21. Thomas, R.L., Dunstan, F.D., Luzio, S.D., et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalm 99 (2015), 64–68.
22. 22. Misra, A., Bachmann, M.O., Greenwood, R.H., et al. Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme. Diabet Med 26 (2009), 1040–1047.
23. 23. Younis, N., Broadbent, D.M., Harding, S.P., Vora, J.P., Incidence of sight-threatening retinopathy in type 1 diabetes in a systematic screening programme. Diabet Med 20 (2003), 758–765.
24. 24. Kristinsson, J.K., Stefansson, E., Jonasson, F., et al. Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol 72 (1994), 341–346.
25. 25. Klein, R., Klein, B.E., Moss, S.E., Davis, M.D., DeMets, D.L., The Wisconsin epidemiologic study of diabetic retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107 (1989), 244–249.
26. 26. Younis, N., Broadbent, D.M., Vora, J.P., Harding, S.P., Incidence of sightthreatening retinopathy in patients with type 2 diabetes in the Liverpool diabetic eye study: A cohort study. Lancet 361 (2003), 195–200.
27. 27. Aspelund, T., Thornórisdóttir, O., Olafsdottir, E., et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia 54 (2011), 2525–2532.
28. 28. Retinopathy Working Party, A protocol for screening for diabetic retinopathy in Europe. Diabet Med 8 (1991), 263–267.
29. 29. Chalk, D., Pitt, M., Vaidya, B., Stein, K., Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?. Diabetes Care 35 (2012), 1663–1668.
30. 30. Thomas, R.L., Dunstan, F., Luzio, S.D., et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the diabetic retinopathy screening Service for Wales: Retrospective analysis. BMJ, 344, 2012, e874.
31. 31. Kalm, H., Diabetic retinopathy screening: Method and strategy. 1993, University of Gothenburg, Gothenburg, Sweden.
32. 32. Scanlon, P.H., Aldington, S.J., Leal, J., Luengo-Fernandez, R., Oke, J., Sivaprasad, S., et al. Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess 19 (2015), 1–116.